FDA clears first treatment for rare male genetic disorder, Barth syndrome
The US Food and Drug Administration (FDA) on Friday approved Stealth Biotherapeutics’ once-daily injection Forzinity for Barth syndrome,…
Browsing Tag
Stealth Biotherapeutics’ Forzinity
1 post